1. Home
  2. UTSI vs BNGO Comparison

UTSI vs BNGO Comparison

Compare UTSI & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UTStarcom Holdings Corp.

UTSI

UTStarcom Holdings Corp.

HOLD

Current Price

$2.42

Market Cap

23.6M

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.19

Market Cap

11.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTSI
BNGO
Founded
1991
2003
Country
China
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Telecommunications
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
23.6M
11.6M
IPO Year
1999
2018

Fundamental Metrics

Financial Performance
Metric
UTSI
BNGO
Price
$2.42
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.50
AVG Volume (30 Days)
3.3K
267.9K
Earning Date
04-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.50
EPS
N/A
N/A
Revenue
N/A
$12,000,735.00
Revenue This Year
N/A
$16.19
Revenue Next Year
N/A
$33.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.26
52 Week Low
$1.94
$1.06
52 Week High
$2.94
$5.50

Technical Indicators

Market Signals
Indicator
UTSI
BNGO
Relative Strength Index (RSI) 48.74 52.09
Support Level $2.34 $1.07
Resistance Level $2.57 $1.64
Average True Range (ATR) 0.11 0.08
MACD 0.00 0.01
Stochastic Oscillator 77.14 29.73

Price Performance

Historical Comparison
UTSI
BNGO

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: